Connect Sign In
ARUP announced the retirement of CEO Sherrie L. Perkins, MD, PhD. ARUP also announced that Andy Theurer has been appointed by the company’s Board of Directors to become CEO.
David Hillyard, MD, ARUP medical director for molecular infectious disease, is among 20 individuals and organizations honored by Utah Business magazine with a Healthcare Hero Award.
A new structure is slowly rising to distinguish the core of University of Utah Research Park. By mid-2021, the building will be the state-of-the-art epicenter of ARUP’s growing operations.
The American Society for Clinical Pathology (ASCP) has recognized two ARUP Laboratories employees through its annual 40 Under Forty Program.
Noriko Kusukawa, PhD, retired July 2 from her position as ARUP Laboratories vice president of innovation and strategic investments after 20 years with the company.
Carl Wittwer, MD, PhD, and Noriko Kusukawa, PhD, who is Wittwer’s wife, are retiring from ARUP Laboratories to move to Maine, where they are building a home with a fully equipped molecular laboratory.
Laboratory employees on the frontlines of COVID-19 testing at ARUP are drawing inspiration from an unexpected source: 1,000 colorful paper cranes.
Clinical laboratory leaders met with Vice President Mike Pence and members of the government’s Coronavirus Task Force to discuss issues related to COVID-19 testing and response.
The Salt Lake Tribune has awarded ARUP Laboratories a Top Workplaces 2019 honor. ARUP is one of 100 Utah companies to receive the award.
Jonathan Genzen, MD, PhD, has been appointed as the new chief operations officer of ARUP Laboratories.
